We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Incidence and prevalence of lower extremity tendinopathy in a Dutch general practice population: a cross sectional study
BMC Musculoskeletal Disordersvolume 17, Article number: 16 (2016)
Lower extremity tendinopathy is a common sports injury, but it can also affect non-athletes. Because tendinopathy is difficult to treat and has negative effects on the ability to work and quality of life, development of preventive interventions is important. The first step in the Van Mechelen prevention model is to determine the extent of the problem. The primary aim of this study was to determine the incidence and prevalence of lower extremity tendinopathy in a Dutch general practice population. The secondary aim was to investigate possible associated factors.
A cross-sectional study was performed in a Dutch general practice. Using International Classification of Primary Care codes, the electronic patient files were searched to identify cases of adductor tendinopathy, greater trochanteric pain syndrome, jumper’s knee, Achilles tendinopathy, and plantar fasciopathy in 2012. The tendinopathy patients were compared to the general practice population regarding age, gender, use of medication, and comorbidity using 95 % confidence intervals.
The prevalence and incidence rates of lower extremity tendinopathy found in this study were 11.83 and 10.52 per 1000 person-years. Lower extremity tendinopathy was more prevalent among older patients. No differences between tendinopathy patients and the general practice population were found regarding gender, use of medication, or comorbidity.
In this cross-sectional study in a Dutch general practice, the prevalence and incidence rates of lower extremity tendinopathy were 11.83 and 10.52 per 1000 person-years. Lower extremity tendinopathy deserves a higher place in locomotor system research to develop preventive interventions.
Lower extremity tendinopathy is a common injury in athletes, but it can also develop in non-athletes [1, 2]. Because tendinopathy can be difficult to treat and might have negative effects on not only sports participation, but also on the ability to work and quality of life [3, 4], development of preventive interventions is of utmost importance.
The first step in the Van Mechelen model for prevention is to determine the extent of the problem . The incidence and prevalence of lower extremity tendinopathy among specific sports populations have been established [6–9]. However, these numbers are largely lacking for the general practice population. The epidemiology of only two lower extremity tendinopathies – Achilles tendinopathy and greater trochanteric pain syndrome – have been studied in Dutch general practice populations [2, 10]. Therefore, the primary aim of this study was to determine the incidence and prevalence of lower extremity tendinopathy among a population visiting a Dutch general practice.
The second step in the Van Mechelen model is to determine risk factors. In previous studies, several factors have been investigated for a possible association with the development of tendinopathy. Aside from increasing age [11, 12], gender differences , and use of medication (corticosteroids, fluoroquinolones, and statins) [14–16], co-morbidities that have been linked to tendinopathy are hypertension, dyslipidaemia, and diabetes mellitus . The secondary aim of this study was to investigate whether in this general practice population an association between tendinopathy and gender, age, use of medication, or co-morbidities could be found.
To determine the incidence and prevalence of lower extremity tendinopathy in a Dutch general practice population, a cross-sectional study was performed at the Academic General Practice Groningen. This group practice of eight general practitioners with more than 10,500 registered patients is part of the morbidity and medication Registration Network Groningen (RNG), which systematically collects patient data in a longitudinal database. The practice was visited to identify cases of lower extremity tendinopathy in the electronic patient files. The following tendinopathies were investigated: adductor tendinopathy, greater trochanteric pain syndrome, jumper’s knee, Achilles tendinopathy, and plantar fasciopathy. Like other general practices in the Netherlands, the Academic General Practice Groningen uses International Classification of Primary Care (ICPC) codes  to document the reason of a patient’s visit. An ICPC code consists of a letter and two numbers, and represents a disease or a symptom. Because there are no specific ICPC codes for lower extremity tendinopathies, a combination of ICPC codes that the general practitioner could have used in the case of lower extremity tendinopathy was used in this study (Table 1). All patient contacts of the year 2012 that matched one of these ICPC codes were studied by ISA to identify cases of tendinopathy.
Because we investigated more than one tendinopathy, there was not a single set of inclusion criteria. Instead, we formulated the inclusion criteria per tendinopathy (Table 2). Patients with bilateral symptoms of one tendinopathy were scored as one case for that specific tendinopathy. Patients with symptoms of two or more different tendinopathies were scored as one case for each of the separate tendinopathies. Patients with tendon ruptures were excluded.
To investigate possible associated factors, we documented age, gender, use of systemic corticosteroids, fluoroquinolones, or statins in the six months before diagnosis, and if the patient suffered from one of the following co-morbidities: diabetes mellitus (defined as ICPC code T90, T90.01, or T90.02), hypertension (defined as ICPC code K86 or K87), and dyslipidaemia (defined as ICPC code T93). We also documented the presence of overweight, defined as an ICPC code (T82 and T83 stand for obesity and overweight, respectively) or a remark about overweight by the general practitioner in the patient file. In addition, we documented the duration of symptoms before the patient visited the general practitioner, and the patient’s sports activities, if this information was available from the patient file.
The number of prevalent and incident cases was divided by the number of person-years in the practice population to determine a prevalence rate (PR) and incidence rate (IR) per 1000 person-years. We used the amount of person-years, because the population of a general practice is dynamic. Throughout the year, the population increases and decreases as a result of birth, death, and migration. The difference between incidence and prevalence was based on patient history. If there had been contacts for the same symptom in 2011, the patient was scored as a prevalent case only. If a patient had not visited the general practitioner for the same symptom in 2011, he or she was scored as both an incident and a prevalent case in 2012.
The tendinopathy patient data were compared to data of the general practice population that were obtained from the annual report of the RNG. We constructed 95 % confidence intervals to test for differences between the tendinopathy patients and the general practice population regarding gender, age, use of medication, and co-morbidities. If the confidence intervals overlapped, the difference was not considered statistically significant. If the confidence intervals did not overlap, the difference was considered statistically significant. SPSS version 22 was used to analyse the data.
The study protocol was reviewed and exempted from requiring ethics approval by the medical ethical committee of the University Medical Center Groningen (METc 2013/516).
Upon registration at the Academic General Practice, patients included in this study gave informed consent to the use of their anonymized data by the Registration Network Groningen.
Between January and April 2014, the Academic General Practice was visited to search the electronic patient files. In 2012, the Academic General Practice contained 10,651 person-years. The combination of ICPC codes provided 1091 hits in the electronic database. Based on the consultation reports, 126 prevalent cases of lower extremity tendinopathy were identified. Fourteen of these patients had visited the general practitioner in 2011 for the same symptoms. This led to a prevalence rate (PR) of 11.83 per 1000 person-years, and an incidence rate (IR) of 10.52 per 1000 person-years. The PR and IR per tendinopathy are shown in Table 3 (Table 3).
The demographics of the tendinopathy patients and the practice population are shown in Table 4 (Table 4). There was no statistically significant difference in the percentages of men and women. The mean age of the tendinopathy patients was significantly higher than the mean age of the practice population.
Twelve of the 126 tendinopathy patients had diabetes (9.5 %; 95 % CI 4.3–14.6 %). This percentage was twice as high as the percentage of patients with diabetes in the general practice population (4.8 %) , but the difference was not statistically significant. Of the tendinopathy patients, 22 had hypertension. The general practitioners made a distinction between essential hypertension (ICPC code K86) and hypertension with organ damage (ICPC code K87). Eighteen tendinopathy patients had essential hypertension. This percentage (14.3 %; 95 % CI 8.1–20.5 %) was not significantly higher than the percentage in the general practice population (11.4 %) . Ten tendinopathy patients had dyslipidaemia (7.9 %).
Fifteen tendinopathy patients used statins (11.9 %; 95 % CI 6.2–16.6 %). This percentage was not significantly higher than the percentage of patients using antilipaemic medication in the total practice population (7.3 %) . Three tendinopathy patients were treated with systemic corticosteroids (2.4 %) and one tendinopathy patient was treated with fluoroquinolones (0.7 %) before the start of the symptoms.
Obesity or overweight were reported in fourteen cases (11.1 %), but no exact data concerning BMI were available. A relationship with sports activities was described in 37 cases (29.4 %). The duration of symptoms before visiting the general practitioner was reported in 40 cases and ranged from one day to six years with a mean of 32 weeks.
Lower extremity tendinopathy has an incidence rate of 10.52 per 1000 person-years and a prevalence rate of 11.83 per 1000 person-years in a Dutch general practice population. The mean age of the tendinopathy patients was higher than the mean age of the general practice population. There were no statistically significant differences between the tendinopathy patients and the general practice population regarding gender, use of medication, or co-morbidities.
This is the first study to investigate the incidence and prevalence of adductor related tendinopathy, jumper’s knee, and plantar fasciopathy in a general practice population. The incidence and prevalence for Achilles tendinopathy in a general practice population has been studied once before; our results are similar to the numbers found by De Jonge et al. in the Netherlands in 2011 . The incidence of greater trochanteric pain syndrome was higher than the incidence of 1.8 per 1000 per year found by Lievense et al. . However, in their study only 54 % of the originally selected patients responded to the questionnaire designed to verify the patients’ symptoms, which could introduce a bias and might explain the difference with our results.
To put the numbers into perspective, the total incidence and prevalence of locomotor system symptoms seen by Dutch general practitioners are 267 and 397 per 1000 persons per year, respectively . The numbers found in our study indicate that the incidence of lower extremity tendinopathy represents 3.0 % of all new locomotor system symptoms seen by general practitioners. In addition, the incidence found for tendinopathy in the current study was higher than the incidence of osteoarthritis in the Dutch general practice population in 2012 (8.4 per 1000 person-years) . While prevention of osteoarthritis is already high on international research agendas , the prevention of tendinopathy has received little attention. The negative impact that tendinopathy can have on the ability to work and quality of life of patients calls for more research into preventive measures, especially because the treatment can be difficult [3, 4].
In the current study, the mean age of tendinopathy patients was significantly higher than the mean age of the general practice population. Earlier studies have found tendinopathy to be more prevalent among older people [11, 12]. The exact mechanism why older tendons seem to be more prone to damage remains to be elucidated. One theory attributes the effect to the accumulation of chronic repetitive damage over time . Another hypothesis is that age-related changes in tendon structure and biomechanics could decrease the loading capacity and regenerative capacity of the tendons .
We found no significant difference in the percentages of men and women when we compared the tendinopathy patients to the practice population. Research among athletes shows different outcomes per tendinopathy. The male gender is considered a risk factor for jumper’s knee [13, 25]. Earlier, the male gender was found to be a risk factor for Achilles tendinopathy as well . However, in athletes over 40 years of age, Longo et al. did not find a difference in risk between men and women . Plantar fasciopathy does not seem to have a male or female predisposition .
Although in the current study the prevalence of diabetes among the tendinopathy patients was twice as high as the prevalence of diabetes in the general practice population, this difference was not statistically significant. This conflicts with earlier research, in which diabetes was found to be a risk factor for tendinopathy . It is possible that our relatively small study population explains this difference in outcomes. There is evidence that diabetes can alter tendon structure, possibly through an excess of advanced glycation end products as a result of hyperglycaemia . In this study, we did not look into the levels of blood glucose in the patients with diabetes. In general, Dutch patients who are being checked by their general practitioner or practice nurse are well regulated. However, we cannot exclude the possibility that poorly regulated or not yet diagnosed patients with diabetes were in the dataset. Gaida et al. have questioned whether the higher risk of tendinopathy associated with diabetes is caused by a disturbance in glucose metabolism per se. They proposed that the higher risk might have to be attributed to the overweight associated with diabetes [30, 31]. The influence of overweight on tendinopathy has been explained in two different ways. One of the theories is that the extra weight leads to an increased loading of the tendons. However, this theory does not explain why non-weight bearing tendons also more often develop tendinopathy in overweight persons . Another theory is that lipocytes have an effect on tendon structure by their metabolic activity . In a recent review on tendinopathy in athletes, Scott et al. state there is evidence for both a mechanical effect and a systemic effect, but the relative contributions of the two mechanisms should be further investigated . In this study, no exact data on BMI of the tendinopathy patients were available.
There were no significant differences in the prevalence of hypertension between the tendinopathy patients and the practice population. Only few patients had dyslipidaemia, so we could not draw conclusions on the association between dyslipidaemia and tendinopathy. We did not have data on how well controlled the patients with hypertension and dyslipidaemia were. Future research could clarify whether developing tendinopathy is related to levels of control of lipids and tension.
Although the use of corticosteroids and fluorquinolones has been identified as a risk factor for developing tendinopathy [14, 15], in this study only few patients were treated with corticosteroids or fluoroquinolones before the start of the symptoms, so we could not draw conclusions on the association between the use of these medications and tendinopathy. The percentage of tendinopathy patients using statins was not significantly different from the percentage of people using antilipaemic drugs in the total practice population. Marie et al. investigated reports on statin-induced tendinous disorders and concluded that these complications are very rare, given the large number of statin prescriptions . The mechanism behind these complications is unknown, but in a rat study De Oliveira et al. described an association between statin treatment and alterations in tendon metabolism .
Several factors could have influenced the outcomes of this study. An important factor is the help-seeking behavior of patients and the organization of (para)medical care in the Netherlands, which could have led to an underestimation of the actual incidence and prevalence of lower extremity tendinopathy in the general population. People with musculoskeletal problems do not always seek professional help. Picavet et al. state that half of the people with musculoskeletal complaints visit a health care professional, and 33 to 42 % of people visit a general practitioner for their complaints . In addition, since 2006 patients do not need to be referred by their general practitioner to visit a physical therapist. Podotherapists are directly accessible since 2011, and in the studied time frame patients did not need to be referred by their general practitioner to visit a sports physician either. People with tendinopathy symptoms could therefore have gone directly to one of these healthcare professionals, instead of visiting their general practitioner. Another factor which could have influenced the outcomes, is the use of ICPC codes. Although a wide combination of ICPC codes was used to identify the cases, it is possible that some cases were missed. A general practitioner could have accidentally given the wrong ICPC code to a consult. In the current study, one case of Achilles tendinopathy was found under the ICPC code L15 (knee complaints).
A factor that could have led to an overestimation of the actual incidence and prevalence of lower extremity tendinopathy, is the inclusion of the greater trochanteric pain syndrome. Although most cases of greater trochanteric pain syndrome are caused by gluteal tendinopathy [34–36], there is a possibility that in some patients the pain was caused by e.g. primary trochanteric bursitis or referred pain from degenerative joint disease.
As this study focused on the epidemiology in primary care, we followed the clinical description and diagnosis as performed by the general practitioners. This entails that the diagnoses were not confirmed by medical imaging as general practitioners rarely order diagnostic imaging when a tendinopathy is suspected. As this was not the scope of this study, validation of these clinical diagnoses by adding additional investigations like medical imaging should be object of future research.
A strength of this study is that it provides insight into the incidence and prevalence of lower extremity tendinopathy among the general practice population, which was currently lacking. It also provides an easily applicable search strategy that allows to investigate multiple tendinopathies at the same time. Limitations of this study are the retrospective design and the relatively small study population, which might hinder extrapolation of the results. However, the numbers for Achilles tendinopathy in the current study were similar to those found by De Jonge et al., who collected data from different geographical locations in the Netherlands .
Lower extremity tendinopathy has an incidence rate of 10.52 per 1000 person-years and a prevalence rate of 11.83 per 1000 person-years in a Dutch general practice population. In contrast to other research, in this general population sample the prevalence of tendinopathy was not higher in patients with diabetes or patients with hypertension. The mean age of the tendinopathy patients was higher than the mean age of the general practice population. In only 29.4 % of the cases, a relationship with sports was described. This indicates that tendinopathy is not only a sports injury, but is common in non-athletes as well. Lower extremity tendinopathy as common and bothersome condition deserves a higher place on the agenda of locomotor system research in order to develop more effective preventive interventions.
Availability of data and materials
The anonymized data set can be requested through ISA.
Rolf C, Movin T. Etiology, histopathology, and outcome of surgery in achillodynia. Foot Ankle Int. 1997;18:565–9.
de Jonge S, van den Berg C, de Vos RJ, van der Heide HJ, Weir A, Verhaar JA, et al. Incidence of midportion Achilles tendinopathy in the general population. Br J Sports Med. 2011;45:1026–8.
Fearon AM, Cook JL, Scarvell JM, Neeman T, Cormick W, Smith PN. Greater trochanteric pain syndrome negatively affects work, physical activity and quality of life: a case control Study. J Arthroplasty. 2014;29:383–6.
van der Worp H, Zwerver J, Kuijer PP, Frings-Dresen MH, van den Akker-Scheek I. The impact of physically demanding work of basketball and volleyball players on the risk for patellar tendinopathy and on work limitations. J Back Musculoskelet Rehabil. 2011;24:49–55.
van Mechelen W, Hlobil H, Kemper HC. Incidence, severity, aetiology and prevention of sports injuries. Sports Med. 1992;14:82–99.
Kujala UM, Sarna S, Kaprio J. Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med. 2005;15:133–5.
Lian OB, Engebretsen L, Bahr R. Prevalence of jumper’s knee among elite athletes from different sports: a cross-sectional study. Am J Sports Med. 2005;33:561–7.
Lopes AD, Hespanhol Jr LC, Yeung SS, Costa LOP. What are the main running-related musculoskeletal injuries? Sports Med. 2012;42:891–905.
Zwerver J, Bredeweg SW, van den Akker-Scheek I. Prevalence of jumper’s knee among nonelite athletes from different sports: a cross-sectional survey. Am J Sports Med. 2011;39:1984–8.
Lievense A, Bierma-Zeinstra S, Schouten B, Bohnen A, Verhaar J, Koes B. Prognosis of trochanteric pain in primary care. Br J Gen Pract. 2005;55:199–204.
Werner RA, Franzblau A, Gell N, Ulin SS, Armstrong TJ. A longitudinal study of industrial and clerical workers: predictors of upper extremity tendonitis. J Occup Rehabil. 2005;15:37–46.
Maffulli N, Wong J, Almekinders LC. Types and epidemiology of tendinopathy. Clin Sports Med. 2003;22:675–92.
de Vries AJ, van der Worp H, Diercks RL, van den Akker-Scheek I, Zwerver J. Risk factors for patellar tendinopathy in volleyball and basketball players: A survey-based prospective cohort study. Scand J Med Sci Sports. 2014. doi:10.1111/sms.12294.
Blanco I, Krähenbühl S, Schlienger RG. Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data. Drug Saf. 2005;28:633–43.
Stahlmann R, Lode HM. Risks associated with the therapeutic use of fluoroquinolones. Expert Opin Drug Saf. 2013;12(4):497–505.
Marie I, Delafenêtre H, Massy N, Thuillez C, Noblet C. Tendinous disorders attributed to statins: A study on ninety‐six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Rheum. 2008;59:367–72.
Abate M, Schiavone C, Salini V, Andia I. Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford). 2013;52:599–608.
Dutch College of General Practitioners. [ICPC-1 5th edition 2010, including annotations version 2013]. Utrecht; 2013. Dutch.
Groenhof F, Wilmink R, Kollen BJ, Berger MY. Registration Network Groningen [Registration Annual Report 2012]. Department of General Practice University Medical Center Groningen: Groningen; 2013. Dutch.
van der Linden MW, Westert GP, de Bakker DH, Schellevis FG. [Second Dutch national survey of general practice. Complaints and illnesses in general practice]. Utrecht/Bilthoven: NIVEL/RIVM; 2004. Dutch.
Ursum J, Hek K, Spronk I, Nielen MMJ, Davids R, Verheij RA.[What is the incidence of osteo-arthritis? From: NIVEL registrations for primary care.] NIVEL. 2013. www.nivel.nl/node/3069. Accessed 8 dec 2015. Dutch.
Chu CR, Millis MB, Olson SA. Osteoarthritis: from palliation to prevention: AOA Critical Issues. J Bone Joint Surg Am. 2014;96:e130.
Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med. 2009;37:1855–67.
Zhou B, Zhou Y, Tang K. An overview of structure, mechanical properties, and treatment for age-related tendinopathy. J Nutr Health Aging. 2014;18:441–8.
van der Worp H, van Ark M, Roerink S, Pepping GJ, van den Akker-Scheek I, Zwerver J. Risk factors for patellar tendinopathy: a systematic review of the literature. Br J Sports Med. 2011;45:446–52.
van Linschoten R, den Hoed P, de Jongh A. [Guideline ‘Chronic Achilles tendinopathy, in particular tendinosis, in sportsmen/sportswomen’]. Ned Tijdschr Geneeskd. 2007;151:2319–24. Dutch.
Longo UG, Rittweger J, Garau G, Radonic B, Gutwasser C, Gilliver SF, et al. No influence of age, gender, weight, height, and impact profile in achilles tendinopathy in masters track and field athletes. Am J Sports Med. 2009;37:1400–5.
Irving DB, Cook JL, Menz HB. Factors associated with chronic plantar heel pain: a systematic review. J Sci Med Sport. 2006;9:11–22.
Miranda H, Viikari-Juntura E, Heistaro S, Heliovaara M, Riihimaki H. A population study on differences in the determinants of a specific shoulder disorder versus nonspecific shoulder pain without clinical findings. Am J Epidemiol. 2005;161:847–55.
Gaida J, Cook J, Bass S. Adiposity and tendinopathy. Disabil Rehabil. 2008;30:1555–62.
Scott A, Zwerver J, Grewal N, de Sa A, Alktebi T, Granville DJ, et al. Lipids, adiposity and tendinopathy: is there a mechanistic link? Critical review. Br J Sports Med. 2015;49:984–8.
de Oliveira LP, Vieira CP, Guerra FDR, de Almeida Mdos S, Pimentel ER. Statins induce biochemical changes in the Achilles tendon after chronic treatment. Toxicology. 2013;311:162–8.
Picavet H, Schouten J. Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC3-study. Pain. 2003;102:167–78.
Eekhof JAH, Knuistingh Neven A, Verheij TJM. [Minor ailments in primary care]. Maarssen: Elsevier gezondheidszorg; 2001. Dutch.
Long SS, Surrey DE, Nazarian LN. Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. Am J Roentgenol. 2013;201:1083–6.
Connell DA, Bass C, Sykes CJ, Young D, Edwards E. Sonographic evaluation of gluteus medius and minimus tendinopathy. Eur Radiol. 2003;13:1339–47.
The authors would like to thank the general practitioners of the Academic General Practice Groningen for their participation in the study.
The authors declare that they have no competing interests.
ISA collected the data, performed the analysis, and drafted the manuscript. JZ participated in the design and coordination of the study and helped to draft the manuscript. RLD was involved in the coordination of the study and helped to draft the manuscript. JHD was involved in the design of the study and data collection and helped to draft the manuscript. IvdAS participated in the design and coordination of the study and helped to draft the manuscript. All authors read and approved the final manuscript.